T. Rowe Price Associates
ZURA icon

T. Rowe Price Associates’s Zura Bio ZURA Stock Holding History

T. Rowe Price Associates’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$286K Buy
+48,385
New +$230K ﹤0.01% 2868
2025
Q2 		– Sell
-20,830
Closed -$27K – 3161
2025
Q1 		$27K Hold
20,830
– – ﹤0.01% 2988
2024
Q4 		$53K Buy
20,830
+5,506
+36% +$19.6K ﹤0.01% 2936
2024
Q3 		$63K Buy
+15,324
New +$57.2K ﹤0.01% 2901

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

T. Rowe Price Associates's ZURA Position: Q2 2026 in Review

T. Rowe Price Associates opened a new position in Zura Bio (ZURA) in Q2 2026: 48,385 shares worth $286K. The stake represents ﹤0.01% of the portfolio and ranks #2868 among its holdings. This is a return to the name: T. Rowe Price Associates previously reported a position in ZURA as recently as Q1 2025.

T. Rowe Price Associates first reported a position in ZURA in Q3 2024 and has held it in 4 quarters since. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • T. Rowe Price Associates held 48,385 shares of Zura Bio worth $286K as of Q2 2026.
  • Zura Bio was a new T. Rowe Price Associates position in Q2 2026.
  • Zura Bio made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2868 holding.
  • T. Rowe Price Associates first reported a position in Zura Bio in Q3 2024 and has held it in 4 quarters since.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.